Intraoperative Brain Microdialysis to Assess Neuroinflammation in Epileptic Tissue Immediately Prior to Surgical Resection.
Withdrawn before enrolling · Not applicable
Conditions studied: Epilepsy
In brief
This research study will investigate the fluid from the area of the brain that is being removed during clinical epilepsy surgery. The goal is to analyze this fluid for inflammatory markers that can potentially help identify new strategies in the future to control seizures in individuals with epilepsy who fail to respond to currently available drugs.
Key facts
- Study ID
- NCT04531722
- Run by
- Mayo Clinic
- People needed
- 0
- Starts
- 2019-03-27
- Expected to finish
- 2026-01-10
- Last updated by the study team
- 2026-04-06
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Failure to respond to at least two trials of anti-seizure drugs with different mechanisms of action
- Normal MRI
You may not qualify if…
- Active immunomodulatory therapy
- Autoimmune disorder
- Signs or symptoms consistent with comorbid infection
- Oncological comorbidity
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.